AU3960400A - Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv - Google Patents

Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv

Info

Publication number
AU3960400A
AU3960400A AU39604/00A AU3960400A AU3960400A AU 3960400 A AU3960400 A AU 3960400A AU 39604/00 A AU39604/00 A AU 39604/00A AU 3960400 A AU3960400 A AU 3960400A AU 3960400 A AU3960400 A AU 3960400A
Authority
AU
Australia
Prior art keywords
metformin
inhibiting
preparation
use
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39604/00A
Inventor
Edoardo Mannucci
Agostino Ognibene
Carlo Maria Rotella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOLTENI L E C DEI FRATELLI ALITTI DI ESERCIZIO SpA Soc
Original Assignee
MOLTENI L E C DEI FLII ALITTI
MOLTENI L E C DEI FRATELLI ALITTI DI ESERCIZIO SpA Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ITFI99A0040 priority Critical
Priority to ITFI990040 priority patent/IT1307844B1/en
Priority to ITFI990215 priority patent/IT1307808B1/en
Priority to ITFI99A0215 priority
Application filed by MOLTENI L E C DEI FLII ALITTI, MOLTENI L E C DEI FRATELLI ALITTI DI ESERCIZIO SpA Soc filed Critical MOLTENI L E C DEI FLII ALITTI
Priority to PCT/EP2000/001849 priority patent/WO2000053171A1/en
Publication of AU3960400A publication Critical patent/AU3960400A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
AU39604/00A 1999-03-05 2000-03-03 Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv Abandoned AU3960400A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITFI99A0040 1999-03-05
ITFI990040 IT1307844B1 (en) 1999-03-05 1999-03-05 Preparation of pharmaceutical composition for treating pathologies requiring the inhibition of the enzyme dipeptidyl peptidase IV
ITFI990215 IT1307808B1 (en) 1999-10-19 1999-10-19 Preparation of pharmaceutical composition for treating pathologies requiring the inhibition of the enzyme dipeptidyl peptidase IV
ITFI99A0215 1999-10-19
PCT/EP2000/001849 WO2000053171A1 (en) 1999-03-05 2000-03-03 Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv

Publications (1)

Publication Number Publication Date
AU3960400A true AU3960400A (en) 2000-09-28

Family

ID=26330588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39604/00A Abandoned AU3960400A (en) 1999-03-05 2000-03-03 Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv

Country Status (2)

Country Link
AU (1) AU3960400A (en)
WO (1) WO2000053171A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19616486C5 (en) 1996-04-25 2016-06-30 Royalty Pharma Collection Trust A method for lowering blood glucose levels in mammals
DE19823831A1 (en) 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim New pharmaceutical use of isoleucyl thiazolidide and its salts
DE19828113A1 (en) 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs of inhibitors of dipeptidyl peptidase IV
DE19828114A1 (en) 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Prodrugs of unstable inhibitors of dipeptidyl peptidase IV
DE19834591A1 (en) 1998-07-31 2000-02-03 Probiodrug Ges Fuer Arzneim Use of substances that decrease the activity of dipeptidyl peptidase IV to increase blood sugar levels, e.g. for treating hypoglycemia
DE19926233C1 (en) 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Production of thiazolidine, useful as pharmaceutical intermediate, comprises reacting hexamethylenetetramine with cysteamine
DE19940130A1 (en) 1999-08-24 2001-03-01 Probiodrug Ges Fuer Arzneim New effectors of dipeptidyl peptidase IV for topical use
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
EP2266665B1 (en) 2000-03-31 2016-05-11 Royalty Pharma Collection Trust Method for the improvement of islet signaling in diabetes mellitus and for its prevention
US6890905B2 (en) 2001-04-02 2005-05-10 Prosidion Limited Methods for improving islet signaling in diabetes mellitus and for its prevention
EP1891948A1 (en) * 2000-10-27 2008-02-27 Probiodrug AG Treatment of neurological and neuropsychological disorders
US7132104B1 (en) 2000-10-27 2006-11-07 Probiodrug Ag Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
RU2003115614A (en) * 2000-10-27 2004-10-27 Пробиодруг Аг (De) A method of treating neurological and neuropsychological disorders
US20030130199A1 (en) 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
SK3622004A3 (en) 2002-02-28 2005-02-04 Prosidion Limited Glutaminyl based DPIV inhibitors
US7368421B2 (en) 2001-06-27 2008-05-06 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
DE10150203A1 (en) 2001-10-12 2003-04-17 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitor in treatment of cancer
US7371871B2 (en) 2003-05-05 2008-05-13 Probiodrug Ag Inhibitors of glutaminyl cyclase
CN101837127A (en) 2003-05-05 2010-09-22 前体生物药物股份公司 Medical use of inhibitors of glutaminyl and glutamate cyclases
EP1675578B9 (en) 2003-10-15 2014-06-25 Probiodrug AG Inhibitors of glutaminyl and glutamate cyclases for the treatment of the neurodegenerative diseases fbd and fdd
DOP2006000008A (en) * 2005-01-10 2006-08-31 Arena Pharm Inc combination therapy for treating diabetes and related conditions and for the treatment of conditions ameliorated by an increase in the blood concentration of glp-1
WO2006086727A2 (en) * 2005-02-09 2006-08-17 Entelos, Inc. Treating diabetes with glucagon-like peptide-1 secretagogues
ES2376351T5 (en) 2005-09-14 2014-07-15 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase for treating diabetes
CN102675221A (en) 2005-09-16 2012-09-19 武田药品工业株式会社 Intermediate in method for preparing pyrimidinedione derivative
GB0526291D0 (en) * 2005-12-23 2006-02-01 Prosidion Ltd Therapeutic method
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
WO2008090198A1 (en) * 2007-01-25 2008-07-31 Janssen Pharmaceutica Nv Use of mtp inhibitors for increasing levels of satiety hormones
EP2146210A1 (en) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
EP0996444B1 (en) * 1997-06-18 2007-03-07 SmithKline Beecham plc Treatment of diabetes with thiazolidinedione and metformin
DE19823831A1 (en) * 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim New pharmaceutical use of isoleucyl thiazolidide and its salts

Also Published As

Publication number Publication date
WO2000053171A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
DZ3313A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
EG24357A (en) New Pharmaceutical composition
DZ3312A1 (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
TWI323256B (en) Novel benzazepine derivatives and pharmaceutical compositions comprising said compounds
AU767394C (en) Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
AU781269C (en) Pharmaceutical compositions
AU2002309885A1 (en) Abuse resistant pharmaceutical composition containing capsaicin
CZ20012028A3 (en) Novel N-substituted 2-cyanopyrrolidines, pharmaceutical preparation in which they are comprised and their use as medicament
IL152022A (en) Compounds useful as protease inhibitors and pharmaceutical compositions containing the same
IL148361D0 (en) Benzylidene-thiazolidinedione derivatives and pharmaceutical compositions containing the same
AU2276801A (en) Extended release oral dosage composition
AU2002215315A1 (en) Composition for the transdermal delivery of fentanyl
AU7719100A (en) Compositions of tocol-soluble therapeutics
IL148384D0 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
HU0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
IL153594D0 (en) Amino alcohol derivatives and pharmaceutical compositions containing the same
HU0400451A3 (en) Pyrrole derivatives and pharmaceutical compositions containing them
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
IL213594D0 (en) Uses of pharmaceutical compositions comprising an alkaoid3
SK15182001A3 (en) Pharmaceutical composition for dermal application
HU0300798A3 (en) Substituted-triazolopyrimidines and their use as anticancer agents and pharmaceutical compositions containing them
HU0204413A3 (en) Quinazoline compounds, their preparation, their use and pharmaceutical compositions containing them
SK18612001A3 (en) 5-cyano-2-aminopyrimidine derivatives and pharmaceutical composition comprising said derivatives
HU0202897A3 (en) Diaminothiazoles and their use for inhibiting protein kinases and pharmaceutical compositions containing them
HU0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase